#104633
#104634
Re: Farmas USA
#104635
Re: Farmas USA
Si, yo tambien he cargado 1/3 menos de lo habitual en TGTX por si le daba por no respetar los 8,90...
#104636
Re: Farmas USA
Pues va a ser solo 1 centimo mas barato que yo porque me entraron a 106,98.
Ale ;)
CELG
Edito: ah, el 25 es el ER Q4
Tambien leo esto: https://stocktwits.com/JorelLaraKalel/message/107563545
#104637
Re: Farmas USA
Amarin sees $230M in sales this year; shares up 3% after hours
Jan. 4, 2018 5:04 PM • SA Editor Douglas W. House
- Amarin (NASDAQ: AMRN) updates investors on Q4 and its outlook for 2018:
- 2017: product revenue: $177M - 180M, including $51M - 54M in Q4. Wholesaler inventory levels of Vascepa within normal ranges at year-end. Accounts receivable: ~$44M (up 120% from a year ago and up 27% from Q3). Cash balance: $73.6M.
- 2018 guidance: revenue: ~$230M, up ~30% each quarter. Guidance will be updated after REDUCE-IT results, expected in late Q3. Revenue this quarter should be $45M - 48M.
#104638
Re: Farmas USA
#104639
Re: Farmas USA
#104640
Re: Farmas USA
No... No puede ser cierto... El mismo que va a colocar los nuevos cromos por ATM dice que BUY? Menudo sorpresón! ;-)
"This prospectus supplement relates to the issuance and sale of up to $75,000,000 of our common stock from time to time through our sales agent, B. Riley FBR, Inc., or BRFBR."
NVAX